• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮康唑诱发的神经后遗症。

Ketoconazole-induced neurologic sequelae.

作者信息

Bulkowstein Mordechai, Mordish Yair, Zimmerman Deena R, Sherman Eliezer, Berkovitch Matitiahu

机构信息

Clinical Pharmacology and Toxicology Unit, Drug Consultation Center, Assaf Harofeh Medical Center, Zerifin, Sackler School of Medicine, Tel-Aviv University.

出版信息

Vet Hum Toxicol. 2003 Oct;45(5):239-40.

PMID:14513889
Abstract

A 77-y-old patient developed weakness of extremities, legs paralysis, dysarthria and tremor 1 h after ingestion of 200 mg ketoconazole for the first time in his life. All complaints faded away within 24 h. Few days later, the patient used another 200 mg ketoconazole tablet, and within an hour experienced a similar clinical picture, which resolved again spontaneously within hours. Laboratory evaluations, including head CT scan, were normal. This case illustrates the need for close vigilance in adverse drug reactions, particularly in the elderly.

摘要

一名77岁患者在首次服用200毫克酮康唑1小时后出现肢体无力、腿部麻痹、构音障碍和震颤。所有不适在24小时内消失。几天后,该患者又服用了一片200毫克的酮康唑,1小时内出现了类似的临床表现,数小时后又自行缓解。包括头部CT扫描在内的实验室检查均正常。该病例表明,对于药物不良反应,尤其是老年患者,需要密切监测。

相似文献

1
Ketoconazole-induced neurologic sequelae.酮康唑诱发的神经后遗症。
Vet Hum Toxicol. 2003 Oct;45(5):239-40.
2
[Major eosinophilia in a premature infant induced by topical ketoconazole].
Ann Dermatol Venereol. 2000 Apr;127(4):405-7.
3
Refractory anaphylactic shock associated with ketoconazole treatment.与酮康唑治疗相关的难治性过敏性休克。
Ann Pharmacother. 2005 Mar;39(3):547-50. doi: 10.1345/aph.1E465. Epub 2005 Feb 8.
4
Baboon syndrome induced by ketoconazole.
Cutan Ocul Toxicol. 2014 Dec;33(4):339-41. doi: 10.3109/15569527.2013.870187. Epub 2014 Mar 18.
5
Population-based case-control study of oral ketoconazole treatment for birth outcomes.
Congenit Anom (Kyoto). 2005 Mar;45(1):5-8. doi: 10.1111/j.1741-4520.2005.00053.x.
6
[Candida infection of the skin and mucous membranes still a topic. Administering azoles with clinical understanding].[皮肤和黏膜念珠菌感染仍是一个话题。临床合理使用唑类药物]
MMW Fortschr Med. 2002 Apr 9;144 Suppl 1:80.
7
Drug safety assessment of oral formulations of ketoconazole.酮康唑口服制剂的药物安全性评估
Expert Opin Drug Saf. 2015 Feb;14(2):325-34. doi: 10.1517/14740338.2015.983071. Epub 2014 Nov 20.
8
Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.两种20毫克氯雷他定口服制剂与酮康唑联用的生物利用度:一项针对健康墨西哥成年志愿者的开放标签、随机、两阶段交叉比较研究。
Clin Ther. 2006 Jan;28(1):110-5. doi: 10.1016/j.clinthera.2006.01.012.
9
Oral candidosis in HIV infection.HIV感染中的口腔念珠菌病。
Lancet. 1989;2(8678-8679):1491-2.
10
A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
J Drugs Dermatol. 2007 Oct;6(10):1001-8.